{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:03:40Z","timestamp":1784577820696,"version":"3.55.0"},"reference-count":33,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Twin Res Hum Genet"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:p>An anonymous survey of Australian Fellows of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists was conducted with the aim of understanding current practice and attitudes toward population-based carrier screening for inherited conditions in the setting of routine pregnancy care. Of 1,121 Fellows invited to complete the online questionnaire by e-mail, 237 (21%) responded, and of these 156 were practicing obstetricians and completed the whole survey. Of the respondents, 83% expressed support for population-based carrier screening for at least some conditions, with 97% supporting carrier screening for \u03b2-thalassaemia, and 83% supporting carrier screening for cystic fibrosis (CF). A small proportion of obstetricians reported offering carrier screening as part of routine pregnancy care (20% for \u03b2-thalassaemia, 8% for CF, 5% for fragile X syndrome, and 2% for spinal muscular atrophy). The main practical barriers identified for screening were cost, time constraints, and availability of supporting services. Addressing these issues is crucial for the successful implementation of population-based carrier screening programs in Australia and internationally.<\/jats:p>","DOI":"10.1017\/thg.2012.152","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T10:47:55Z","timestamp":1358765275000},"page":"601-607","source":"Crossref","is-referenced-by-count":21,"title":["Current Practice and Attitudes of Australian Obstetricians Toward Population-Based Carrier Screening for Inherited Conditions"],"prefix":"10.1017","volume":"16","author":[{"given":"Zornitza","family":"Stark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"McClaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liane","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cousens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Delatycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2013,1,21]]},"reference":[{"key":"S1832427412001521_ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199905000-00002"},{"key":"S1832427412001521_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92403-G"},{"key":"S1832427412001521_ref30","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2011.134"},{"key":"S1832427412001521_ref27","unstructured":"RANZCOG. (2010). Prenatal screening for fetal abnormalities. A statement from the The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Retrieved from http:\/\/www.ranzcog.edu.au\/publications\/collegestatements.shtml."},{"key":"S1832427412001521_ref26","unstructured":"RANZCOG. (2009). College statement: Pre-pregnancy counselling and routine antenatal assessment in the absence of pregnancy complications. Retrieved from http:\/\/www.ranzcog.edu.au\/publications\/statements\/C-obs3.pdf."},{"key":"S1832427412001521_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01.GIM.0000139509.04177.4B"},{"key":"S1832427412001521_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90476-J"},{"key":"S1832427412001521_ref12","unstructured":"Human Genetics Society of Australasia (HGSA). (2009). Cystic fibrosis population screening position paper. Retrieved from http:\/\/www.hgsa.com.au\/images\/UserFiles\/Attachments\/CysticFibrosisPositionPaper.pdf"},{"key":"S1832427412001521_ref7","doi-asserted-by":"publisher","DOI":"10.1375\/twin.11.4.422"},{"key":"S1832427412001521_ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.90"},{"key":"S1832427412001521_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08369-1"},{"key":"S1832427412001521_ref2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1815"},{"key":"S1832427412001521_ref1","volume-title":"Preconception and prenatal carrier screening for cystic fibrosis","year":"2001"},{"key":"S1832427412001521_ref19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5694\/j.1326-5377.2011.tb03781.x","article-title":"A case for cystic fibrosis carrier testing in the general population","volume":"194","author":"McClaren","year":"2011","journal-title":"Medical Journal of Australia"},{"key":"S1832427412001521_ref25","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000163251.54416.a6"},{"key":"S1832427412001521_ref21","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31817c036e"},{"key":"S1832427412001521_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33290"},{"key":"S1832427412001521_ref28","first-page":"1024","article-title":"Beta-thalassemia disease prevention: Genetic medicine applied","volume":"36","author":"Scriver","year":"1984","journal-title":"American Journal of Human Genetics"},{"key":"S1832427412001521_ref23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5694\/j.1326-5377.2010.tb03836.x","article-title":"Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening","volume":"193","author":"Modra","year":"2010","journal-title":"Medical Journal of Australia"},{"key":"S1832427412001521_ref22","first-page":"285","article-title":"Social consequences of introducing antenatal diagnosis for thalassemia","volume":"18","author":"Modell","year":"1982","journal-title":"Birth Defects Original Article Series"},{"key":"S1832427412001521_ref16","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp08X277276"},{"key":"S1832427412001521_ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0707530"},{"key":"S1832427412001521_ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1758"},{"key":"S1832427412001521_ref14","first-page":"13","volume-title":"Tay-Sachs disease, screening and prevention","author":"Kaback","year":"1997"},{"key":"S1832427412001521_ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550150077039"},{"key":"S1832427412001521_ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.78"},{"key":"S1832427412001521_ref11","unstructured":"Hausen J. (2012, February 26). Gardiner couple sues medical providers in wrongful birth case. Bozeman Daily Chronicle."},{"key":"S1832427412001521_ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017067"},{"key":"S1832427412001521_ref10","first-page":"225","article-title":"Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice","volume":"46","author":"Harris","year":"1996","journal-title":"British Journal of General Practice"},{"key":"S1832427412001521_ref33","first-page":"769","article-title":"A private view of heterozygosity: Eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal","volume":"18","author":"Zeesman","year":"1984","journal-title":"American Journal of Human Genetics"},{"key":"S1832427412001521_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1984.tb00781.x"},{"key":"S1832427412001521_ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2009.01045.x"},{"key":"S1832427412001521_ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2010.01459.x"}],"container-title":["Twin Research and Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1832427412001521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T20:36:17Z","timestamp":1595277377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1832427412001521\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,21]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1832427412001521"],"URL":"https:\/\/doi.org\/10.1017\/thg.2012.152","relation":{},"ISSN":["1832-4274","1839-2628"],"issn-type":[{"value":"1832-4274","type":"print"},{"value":"1839-2628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,21]]}}}